International Journal of Clinical Research

Objective To analyze the clinical value of treating elderly patients with hypertension with Ginkgo biloba drop pills combined with valsartan Capsules. Methods Elderly patients with hypertension admitted to our hospital from April 2023 to April 2025 were selected for a group control study. According to the digital random table method, 130 enrolled patients were divided into two groups, with 65 cases in each group. All patients received conventional symptomatic treatment. The control group was given valsartan capsules, and the observation group was given Ginkgo biloba drop pills combined with valsartan capsules. The intervention effects of the two groups were evaluated based on clinical treatment outcomes, blood pressure levels, and vascular endothelial function. Results The results of the clinical efficacy evaluation show that the total effective rate of the observation group was significantly higher than that of the control group (P < 0.05). After treatment, the systolic blood pressure (SBP) and diastolic blood pressure (DBP) in the observation group decreased significantly compared with those in the control group, and there was a statistically significant difference between the groups (P < 0.05). After treatment, the nitric oxide (NO) and endothelin-1 (ET-1) in the observation group were significantly improved compared with those in the control group, and there was a statistically significant difference between the groups (P < 0.05). Conclusion The use of Ginkgo biloba drop pills combined with valsartan capsules in elderly patients with hypertension can further enhance the clinical efficacy, lower blood pressure indicators, and improve vascular endothelial function.

Old age; Hypertension; Ginkgo Biloba Drop Pills; Valsartan capsules